<DOC>
	<DOC>NCT00323817</DOC>
	<brief_summary>To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia</brief_summary>
	<brief_title>To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>Subjects presenting diagnosis of FD as defined by the Rome II Subjects presenting postprandial fullness and/or Early satiety should be the most bothersome symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>